David Li
Lawyers

Associate in our Capital Markets practice.
David advises U.S. and non-U.S. companies and investment banks on capital markets transactions, including initial public offerings, follow-on equity offerings and investment-grade and high-yield debt offerings. His practice ranges across a variety of industries, with particular focus on biotech and technology.
Experience highlights
Recent Representations
- Gates Industrial $203 million secondary offering
- BMS $35 million investment in Immatics
- Gates Industrial $304 million secondary offering
- InflaRx follow-on offering
- Advance Auto Parts $600 million notes offering
- ADC Therapeutics secondary offering
- Chart Industries $1.97 billion notes offering
- Chart Industries $1.1 billion common and depositary share offerings
- Immatics $110 million follow-on offering
- Alignment Healthcare $132.75 million secondary offering
- ADC Therapeutics $175 million term loan facility and other financings
- Canada $3.5 billion global bond offering
- Excelerate Energy $384 million IPO
- Gates Industrial $87.1 million secondary offering
- Advance Auto Parts $350 million notes offering
- Gates Industrial $460 million secondary offering
Education
J.D., Harvard Law School
- magna cum laude
- Senior Editor, Harvard Law Review
B.Sc., Psychology, University of Toronto
Professional history
- Davis Polk since 2018
Qualifications and admissions
- State of New York